alendronate has been researched along with lactic acid in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (35.71) | 29.6817 |
2010's | 18 (64.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atilla Hincal, A; Calis, S; Samdancioglu, S; Sumnu, M | 1 |
Cohen-Sela, E; Danenberg, HD; Epstein, H; Gao, J; Gati, I; Golomb, G; Reich, R; Rosenzweig, O | 1 |
Choi, SW; Kim, JH | 1 |
El-Khordagui, LK; El-Massik, MA; Khalafallah, NM; Marei, MK; Nafea, EH | 1 |
Avnet, S; Baldini, N; Castelli, F; Cenni, E; Fotia, C; Granchi, D; Micieli, D; Pignatello, R; Salerno, M; Sarpietro, MG | 3 |
Chorny, M; Cohen-Sela, E; Danenberg, HD; Golomb, G; Koroukhov, N | 1 |
Gong, Y; Ren, L; Shi, X; Wang, DA; Wang, Y | 1 |
Brunette, DM; Burt, HM; Chehroudi, B; Jackson, JK; Long, KA; Yang, C | 1 |
Ren, L; Shi, X; Varshney, RR; Wang, DA; Wang, Y; Zhang, F | 1 |
Ren, L; Shi, X; Wang, DA; Wang, Y; Yao, Y | 1 |
Chang, JK; Chen, CH; Chen, SM; Ho, ML; Wang, CK; Wang, CZ; Wang, GJ | 1 |
Brunette, DM; Burt, HM; Chakraborti, M; Jackson, JK; Plackett, D | 1 |
Gryczynski, Z; Ranjan, AP; Raut, SL; Thamake, SI; Vishwanatha, JK | 1 |
Bhaduri, SB; Zhou, H | 1 |
Baron, R; Basto, P; Bertrand, N; Farokhzad, OC; Ghobrial, IM; Glavey, S; Kamaly, N; Liu, J; Lu, ZN; Manier, S; Memarzadeh, M; Mishima, Y; Moschetta, M; Nagano, K; Reagan, MR; Roccaro, AM; Sacco, A; Seevaratnam, D; Shi, J; Swami, A; Wu, J; Zhang, S; Zhang, Y | 1 |
Dorval Courchesne, NM; Hammond, PT; Hyder, MN; Nevins, M; Quadir, MA; Seeherman, HJ; Shah, NJ; Spector, M | 1 |
Aspenberg, P | 1 |
Bae, J; Park, JW | 1 |
Bacakova, L; Filova, E; Kamperman, M; Pamula, E; Parizek, M; Posadowska, U; Wlodarczyk-Biegun, M | 1 |
Ding, CW; Li, JM; Li, YH; Wang, W; Wang, ZD; Zhang, HX | 1 |
Cong, Y; Huang, G; Jiang, Q; Liu, J; Liu, M; Quan, C; Tong, G; Yin, Y; Zhang, C | 1 |
Batista, JD; de Melo, GB; Dechichi, P; GuimarĂ£es-Henriques, JC; Limirio, PH; Rocha, FS | 1 |
Feng, RJ; Li, D; Li, QH; Liu, P; Sun, L; Wang, YH; Zhang, P; Zhou, DS | 1 |
Li, N; Shi, X; Song, J; Wang, Y; Zhu, G | 1 |
Chang, JK; Chen, CH; Fu, YC; Ho, ML; Rajalakshmanan, E; Tsai, TL; Wang, CK; Wang, YH | 1 |
Hu, Y; Lei, P; Liu, G; Liu, H; Niu, W; Ruan, J; Shrike Zhang, Y; Wu, H; Xie, J; Yang, J; Zhang, C; Zhang, L | 1 |
28 other study(ies) available for alendronate and lactic acid
Article | Year |
---|---|
Formulation and in vitro evaluation of bisphosphonate loaded microspheres for implantation in osteolysis.
Topics: Alendronate; Bone Density Conservation Agents; Chemistry, Pharmaceutical; Chitosan; Drug Implants; Emulsions; Lactic Acid; Microspheres; Osteolysis; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility; Solvents; Surface Properties | 2006 |
Alendronate-loaded nanoparticles deplete monocytes and attenuate restenosis.
Topics: Alendronate; Animals; Cell Line; Cell Proliferation; Constriction, Pathologic; Dose-Response Relationship, Drug; Hypercholesterolemia; Injections, Subcutaneous; Lactic Acid; Macrophages; Mice; Monocytes; Nanostructures; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Time Factors | 2006 |
Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone.
Topics: Adsorption; Alendronate; Bone and Bones; Drug Carriers; Drug Delivery Systems; Drug Design; Durapatite; Lactic Acid; Magnetic Resonance Spectroscopy; Molecular Weight; Nanoparticles; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Spectrophotometry, Ultraviolet | 2007 |
Alendronate PLGA microspheres with high loading efficiency for dental applications.
Topics: Alendronate; Drug Carriers; Hydrogen-Ion Concentration; Kinetics; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Sodium | 2007 |
Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate.
Topics: Alendronate; Alkaline Phosphatase; Cell Survival; Hemolysis; Humans; Lactic Acid; Leukocyte Count; Microscopy, Electron, Scanning; Nanoparticles; Platelet Activation; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2008 |
A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles.
Topics: Acetates; Alendronate; Animals; Biological Availability; Bone Density Conservation Agents; Carotid Stenosis; Cell Line; Cell Proliferation; Drug Carriers; Drug Compounding; Emulsions; Hydrogen-Ion Concentration; Lactic Acid; Macrophages; Male; Monocytes; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Rats; Secondary Prevention; Sonication; Surface-Active Agents | 2009 |
Enhancing alendronate release from a novel PLGA/hydroxyapatite microspheric system for bone repairing applications.
Topics: Alendronate; Alkaline Phosphatase; Bone Density Conservation Agents; Bone Regeneration; Cell Proliferation; Cells, Cultured; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Durapatite; Emulsions; Humans; Kinetics; Lactic Acid; Macrophages; Microspheres; Osteoblasts; Osteogenesis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Surface Properties | 2009 |
A novel biomaterial for osteotropic drug nanocarriers: synthesis and biocompatibility evaluation of a PLGA-ALE conjugate.
Topics: Alendronate; Biocompatible Materials; Cells, Cultured; Drug Carriers; Humans; Lactic Acid; Magnetic Resonance Spectroscopy; Microscopy, Electron, Scanning; Molecular Structure; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2009 |
Controlled release of alendronate from polymeric films.
Topics: Alendronate; Alkaline Phosphatase; Animals; Biocompatible Materials; Bone Density Conservation Agents; Cell Survival; Cells, Cultured; Delayed-Action Preparations; Drug Carriers; Lactic Acid; Materials Testing; Microscopy, Electron, Scanning; Osteoblasts; Polyesters; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Powder Diffraction; Rats; Surface Properties; Thermodynamics | 2009 |
In-vitro osteogenesis of synovium stem cells induced by controlled release of bisphosphate additives from microspherical mesoporous silica composite.
Topics: Alendronate; Animals; Bone Density Conservation Agents; Cells, Cultured; Drug Carriers; Durapatite; Lactic Acid; Mesenchymal Stem Cells; Microspheres; Osteogenesis; Phosphatidic Acids; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Silicon Dioxide; Synovial Membrane | 2009 |
In vitro osteogenesis of synovium mesenchymal cells induced by controlled release of alendronate and dexamethasone from a sintered microspherical scaffold.
Topics: Alendronate; Animals; Cell Differentiation; Delayed-Action Preparations; Dexamethasone; Drug Carriers; Durapatite; Glycolates; Lactic Acid; Mechanical Phenomena; Mesenchymal Stem Cells; Microspheres; Osteogenesis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Spectroscopy, Fourier Transform Infrared; Synovial Membrane; Tissue Scaffolds | 2010 |
The effect of the local delivery of alendronate on human adipose-derived stem cell-based bone regeneration.
Topics: Adipose Tissue; Alendronate; Alkaline Phosphatase; Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Calcification, Physiologic; Cells, Cultured; Drug Delivery Systems; Humans; Immunohistochemistry; Implants, Experimental; In Situ Hybridization, Fluorescence; Lactic Acid; Male; Osteogenesis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Skull; Stem Cells; Wound Healing | 2010 |
Drug intercalation in layered double hydroxide clay: application in the development of a nanocomposite film for guided tissue regeneration.
Topics: Alendronate; Alkaline Phosphatase; Aluminum Silicates; Animals; Biocompatible Materials; Cell Survival; Cells, Cultured; Clay; Drug Carriers; Drug Combinations; Guided Tissue Regeneration; Hydroxides; Lactic Acid; Nanocomposites; Osteoblasts; Osteogenesis; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Surface Properties; Tetracycline | 2011 |
The effect of poly(d,l-lactide-co-glycolide)-alendronate conjugate nanoparticles on human osteoclast precursors.
Topics: Actins; Alendronate; Apoptosis; Bone Density Conservation Agents; Bone Neoplasms; Cells, Cultured; Collagen Type I; Dose-Response Relationship, Drug; Humans; Lactic Acid; Nanoparticles; Osteoclasts; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proteolysis; Proton Magnetic Resonance Spectroscopy | 2012 |
Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer.
Topics: Alendronate; Animals; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Boronic Acids; Bortezomib; Breast Neoplasms; Curcumin; Drug Carriers; Female; Humans; Lactic Acid; Mice; Mice, Nude; Nanoparticles; Neoplasm Metastasis; Osteoporosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrazines | 2012 |
Deposition of PLA/CDHA composite coating via electrospraying.
Topics: Alendronate; Animals; Biocompatible Materials; Calcium; Cell Adhesion; Cell Differentiation; Cell Line; Durapatite; Lactic Acid; Mice; Osteoblasts; Polyesters; Polymers; Surface Properties | 2013 |
Engineered nanomedicine for myeloma and bone microenvironment targeting.
Topics: Alendronate; Animals; Antineoplastic Agents; Bone Neoplasms; Boronic Acids; Bortezomib; Cell Line, Tumor; Drug Delivery Systems; Heterografts; Humans; Lactic Acid; Mice; Mice, Inbred BALB C; Mice, Nude; Multiple Myeloma; Nanoparticles; Neoplasm Transplantation; Neoplasms, Experimental; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrazines; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2014 |
Adaptive growth factor delivery from a polyelectrolyte coating promotes synergistic bone tissue repair and reconstruction.
Topics: Alendronate; Angiogenesis Inducing Agents; Animals; Becaplermin; Biocompatible Materials; Bone and Bones; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Regeneration; Disease Models, Animal; Lactic Acid; Male; Membranes, Artificial; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proto-Oncogene Proteins c-sis; Rats; Rats, Sprague-Dawley; Regenerative Medicine; Skull; Wound Healing | 2014 |
Alendronate-eluting polyglucose-lignol composite (POGLICO): a new biomaterial for fracture fixating implants.
Topics: Alendronate; Animals; Bone Density Conservation Agents; Bone Screws; Coated Materials, Biocompatible; Glucans; Internal Fixators; Lactic Acid; Male; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Radiography; Random Allocation; Rats, Sprague-Dawley; Tibial Fractures | 2014 |
Preparation of an injectable depot system for long-term delivery of alendronate and evaluation of its anti-osteoporotic effect in an ovariectomized rat model.
Topics: Alendronate; Animals; Bone Density; Bone Density Conservation Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Disease Models, Animal; Drug Delivery Systems; Emulsions; Female; Hyaluronic Acid; Injections, Intramuscular; Lactic Acid; Male; Microspheres; Osteoporosis; Ovariectomy; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Rats; Rats, Sprague-Dawley | 2015 |
Injectable nanoparticle-loaded hydrogel system for local delivery of sodium alendronate.
Topics: Alendronate; Animals; Bone Density Conservation Agents; Cell Differentiation; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Humans; Hydrogels; Injections; Kinetics; Lactic Acid; Mice; Nanoparticles; Nanotechnology; Osteoblasts; Osteoclasts; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polysaccharides, Bacterial; RANK Ligand; RAW 264.7 Cells; Rheology; Solubility; Technology, Pharmaceutical | 2015 |
The biocompatibility of calcium phosphate cements containing alendronate-loaded PLGA microparticles in vitro.
Topics: Alendronate; Animals; Biocompatible Materials; Bone and Bones; Bone Cements; Calcium Phosphates; Cell Adhesion; Cell Cycle; Cell Differentiation; Cell Proliferation; Compressive Strength; Flow Cytometry; Lactic Acid; Male; Mesenchymal Stem Cells; Microscopy, Electron, Scanning; Microspheres; Osteogenesis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Rabbits; Tissue Engineering; Tissue Scaffolds | 2015 |
Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin.
Topics: Alendronate; Animals; Anti-Bacterial Agents; Bone and Bones; Cell Line; Cell Line, Tumor; Drug Carriers; Drug Liberation; Durapatite; Humans; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Methicillin-Resistant Staphylococcus aureus; Micelles; Microbial Sensitivity Tests; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Polymers; Rats; Vancomycin | 2015 |
The Effect of Local Delivery Doxycycline and Alendronate on Bone Repair.
Topics: Alendronate; Animals; Bone and Bones; Bone Density Conservation Agents; Bone Regeneration; Doxycycline; Drug Delivery Systems; Lactic Acid; Male; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar | 2016 |
Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarcoma.
Topics: Alendronate; Animals; Bone Neoplasms; Cell Line, Tumor; Cisplatin; Dextrans; Drug Carriers; Humans; Lactic Acid; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Osteosarcoma; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Xenograft Model Antitumor Assays | 2015 |
Alendronate conjugated nanoparticles for calcification targeting.
Topics: Alendronate; Animals; Bone Density Conservation Agents; Calcification, Physiologic; Cell Proliferation; Cell Survival; Dopamine; Drug Carriers; Durapatite; Humans; Hydrogels; Lactic Acid; Mice; Nanoparticles; NIH 3T3 Cells; Particle Size; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymerization | 2016 |
PLGA-linked alendronate enhances bone repair in diaphysis defect model.
Topics: Alendronate; Animals; Delayed-Action Preparations; Diaphyses; Femur; Lactic Acid; Male; Osteogenesis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; X-Ray Microtomography | 2017 |
Reconstruction of Large-scale Defects with a Novel Hybrid Scaffold Made from Poly(L-lactic acid)/Nanohydroxyapatite/Alendronate-loaded Chitosan Microsphere: in vitro and in vivo Studies.
Topics: Alendronate; Animals; Bone Regeneration; Bone Substitutes; Cells, Cultured; Chitosan; Drug Delivery Systems; Durapatite; In Vitro Techniques; Lactic Acid; Microspheres; Osteogenesis; Rabbits; Tissue Engineering; Tissue Scaffolds | 2017 |